Treatment of interleukin-1 receptor antagonist in combination with methotrexate (MTX) in rheumatoid arthritis (RA) patients.

被引:0
|
作者
Cohen, S
Hurd, E
Cush, JJ
Schiff, MH
Weinblatt, ME
Moreland, IW
Bear, M
Rich, W
McCabe, DP
机构
来源
ARTHRITIS AND RHEUMATISM | 1999年 / 42卷 / 09期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1217
引用
收藏
页码:S273 / S273
页数:1
相关论文
共 50 条
  • [1] Treatment of rheumatoid arthritis by interleukin-1 receptor antagonist
    Wendling, D
    Jorgensen, C
    [J]. REVUE DE MEDECINE INTERNE, 2002, 23 (12): : 1006 - 1011
  • [2] Anakinra - An interleukin-1 receptor antagonist for treatment of rheumatoid arthritis
    Small, RE
    Wixted, MA
    Roberts, WN
    [J]. FORMULARY, 2001, 36 (03) : 191 - +
  • [3] Treatment of patients with rheumatoid arthritis with the interleukin-1 receptor antagonist anakinra (Kineret®)
    Rubbert-Roth, A
    Perniok, A
    [J]. ZEITSCHRIFT FUR RHEUMATOLOGIE, 2003, 62 (04): : 367 - 377
  • [4] Effects of renal insufficiency on pharmacokinetics of methotrexate (MTX) in rheumatoid arthritis (RA) patients.
    Combe, B
    Kinowski, JM
    Bologna, C
    Sany, J
    Bressolle, F
    [J]. ARTHRITIS AND RHEUMATISM, 1997, 40 (09): : 382 - 382
  • [5] Folic acid alters methotrexate (MTX) disposition in rheumatoid arthritis (RA) patients.
    Combe, B
    Kinowski, JM
    Pouly, B
    Sany, J
    Bressolle, F
    [J]. ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S76 - S76
  • [6] The use of anakinra, an interleukin-1 receptor antagonist, in the treatment of rheumatoid arthritis
    Cohen, SB
    [J]. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2004, 30 (02) : 365 - +
  • [7] Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist
    Bresnihan, B
    Alvaro-Gracia, JM
    Cobby, M
    Doherty, M
    Domljan, Z
    Emery, P
    Nuki, G
    Pavelka, K
    Rau, R
    Rozman, B
    Watt, I
    Williams, B
    Aitchison, R
    McCabe, D
    Musikic, P
    [J]. ARTHRITIS AND RHEUMATISM, 1998, 41 (12): : 2196 - 2204
  • [8] Interleukin-1 and the interleukin-1 receptor antagonist gene polymorphisms study in patients with rheumatoid arthritis
    Allam, I.
    Djidjik, R.
    Ouikhlef, N.
    Louahchi, S.
    Raaf, N.
    Behaz, N.
    Abdessemed, A.
    Khaldoun, N.
    Tahiat, A.
    Bayou, M.
    Ladjouze-Rezig, A.
    Ghaffor, M.
    [J]. PATHOLOGIE BIOLOGIE, 2013, 61 (06): : 264 - 268
  • [9] The safety and efficacy of interleukin-1 receptor antagonist in the treatment of rheumatoid arthritis
    Bresnihan, B
    [J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 2001, 30 (05) : 17 - 20
  • [10] Interleukin-1β and interleukin-1 receptor antagonist gene polymorphisms in rheumatoid arthritis
    Huang, CM
    Tsai, FJ
    Wu, JY
    Wu, MC
    [J]. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2001, 30 (04) : 225 - 228